These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21306558)

  • 1. Insights into the fate of the N-terminal amyloidogenic polypeptide of ApoA-I in cultured target cells.
    Arciello A; De Marco N; Del Giudice R; Guglielmi F; Pucci P; Relini A; Monti DM; Piccoli R
    J Cell Mol Med; 2011 Dec; 15(12):2652-63. PubMed ID: 21306558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.
    Mizuguchi C; Nakagawa M; Namba N; Sakai M; Kurimitsu N; Suzuki A; Fujita K; Horiuchi S; Baba T; Ohgita T; Nishitsuji K; Saito H
    J Biol Chem; 2019 Sep; 294(36):13515-13524. PubMed ID: 31341020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-binding cassette A1-mediated lipidation of apolipoprotein A-I occurs at the plasma membrane and not in the endocytic compartments.
    Denis M; Landry YD; Zha X
    J Biol Chem; 2008 Jun; 283(23):16178-86. PubMed ID: 18385134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation.
    Monti DM; Guglielmi F; Monti M; Cozzolino F; Torrassa S; Relini A; Pucci P; Arciello A; Piccoli R
    Eur Biophys J; 2010 Aug; 39(9):1289-99. PubMed ID: 20182709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroendocytosis pathway of ABCA1/apoA-I contributes to HDL formation.
    Azuma Y; Takada M; Shin HW; Kioka N; Nakayama K; Ueda K
    Genes Cells; 2009 Feb; 14(2):191-204. PubMed ID: 19170766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease.
    Neufeld EB; Stonik JA; Demosky SJ; Knapper CL; Combs CA; Cooney A; Comly M; Dwyer N; Blanchette-Mackie J; Remaley AT; Santamarina-Fojo S; Brewer HB
    J Biol Chem; 2004 Apr; 279(15):15571-8. PubMed ID: 14747463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the interaction of the N-terminal amyloidogenic polypeptide of ApoA-I with model cellular membranes.
    Rusciano G; Pesce G; Zito G; Sasso A; Gaglione R; Del Giudice R; Piccoli R; Monti DM; Arciello A
    Biochim Biophys Acta; 2016 Apr; 1860(4):795-801. PubMed ID: 26820473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo.
    Chroni A; Liu T; Gorshkova I; Kan HY; Uehara Y; Von Eckardstein A; Zannis VI
    J Biol Chem; 2003 Feb; 278(9):6719-30. PubMed ID: 12488454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular lipidation of newly synthesized apolipoprotein A-I in primary murine hepatocytes.
    Maric J; Kiss RS; Franklin V; Marcel YL
    J Biol Chem; 2005 Dec; 280(48):39942-9. PubMed ID: 16204232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.
    Mizuguchi C; Ogata F; Mikawa S; Tsuji K; Baba T; Shigenaga A; Shimanouchi T; Okuhira K; Otaka A; Saito H
    J Biol Chem; 2015 Aug; 290(34):20947-20959. PubMed ID: 26175149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation.
    Adachi E; Nakajima H; Mizuguchi C; Dhanasekaran P; Kawashima H; Nagao K; Akaji K; Lund-Katz S; Phillips MC; Saito H
    J Biol Chem; 2013 Jan; 288(4):2848-56. PubMed ID: 23233678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Phosphatidylserine and Cholesterol on Membrane-mediated Fibril Formation by the N-terminal Amyloidogenic Fragment of Apolipoprotein A-I.
    Mizuguchi C; Nakamura M; Kurimitsu N; Ohgita T; Nishitsuji K; Baba T; Shigenaga A; Shimanouchi T; Okuhira K; Otaka A; Saito H
    Sci Rep; 2018 Apr; 8(1):5497. PubMed ID: 29615818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity.
    Liz MA; Gomes CM; Saraiva MJ; Sousa MM
    J Lipid Res; 2007 Nov; 48(11):2385-95. PubMed ID: 17693625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of cdc42/Rho kinase in apoA-I-mediated cholesterol efflux through interaction between cytosolic lipid-protein particles and microtubules in rat astrocytes.
    Kheirollah A; Nagayasu Y; Ueda H; Yokoyama S; Michikawa M; Ito J
    J Neurosci Res; 2014 Apr; 92(4):455-63. PubMed ID: 24446142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles.
    Liu L; Bortnick AE; Nickel M; Dhanasekaran P; Subbaiah PV; Lund-Katz S; Rothblat GH; Phillips MC
    J Biol Chem; 2003 Oct; 278(44):42976-84. PubMed ID: 12928428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of ATP binding cassette protein A1 expression and ApoA-I lipidation by Niemann-Pick type C1 in murine hepatocytes and macrophages.
    Wang MD; Franklin V; Sundaram M; Kiss RS; Ho K; Gallant M; Marcel YL
    J Biol Chem; 2007 Aug; 282(31):22525-33. PubMed ID: 17553802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylethanolamine accelerates aggregation of the amyloidogenic N-terminal fragment of apoA-I.
    Kurimitsu N; Mizuguchi C; Fujita K; Taguchi S; Ohgita T; Nishitsuji K; Shimanouchi T; Saito H
    FEBS Lett; 2020 May; 594(9):1443-1452. PubMed ID: 31968125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an amyloid fibril forming peptide comprising residues 46-59 of apolipoprotein A-I.
    Wong YQ; Binger KJ; Howlett GJ; Griffin MD
    FEBS Lett; 2012 Jun; 586(13):1754-8. PubMed ID: 22609356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polyphenol (-)-epigallocatechin-3-gallate prevents apoA-IIowa amyloidosis in vitro and protects human embryonic kidney 293 cells against amyloid cytotoxicity.
    Nakajima H; Nishitsuji K; Kawashima H; Kuwabara K; Mikawa S; Uchimura K; Akaji K; Kashiwada Y; Kobayashi N; Saito H; Sakashita N
    Amyloid; 2016; 23(1):17-25. PubMed ID: 26701221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I.
    Chan GK; Witkowski A; Gantz DL; Zhang TO; Zanni MT; Jayaraman S; Cavigiolio G
    J Biol Chem; 2015 Apr; 290(17):10958-71. PubMed ID: 25759391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.